Oncoceutics Competitors and Similar CompaniesClear all

Oncoceutics's competitors and similar companies include Vivoryon Therapeutics, Moleculin Biotech, Werewolf Therapeutics and Shanghai Junshi Biosciences.
Oncoceutics
Oncoceutics
Oncoceutics is a drug discovery and development company focused on selective G protein-coupled receptor antagonists for oncology.
Vivoryon Therapeutics
Vivoryon Therapeutics
Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases.
Moleculin Biotech
Moleculin Biotech
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
Werewolf Therapeutics
Werewolf Therapeutics
Werewolf Therapeutics is an oncology biotherapeutics company that develops cancer treatments designed to focus the body’s immune response to selectively target cancer.
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date
Founding Date
2009
Founding Date
1997
Founding Date
2006
Founding Date
2017
Founding Date
2012
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Locations
Halle (Saale), DE HQ
München, DE
Locations
Houston, US HQ
Locations
Cambridge, US HQ
Locations
Shanghai, CN HQ
Employees
Employees
12
Employees
15
Employees
1910% decrease
Employees
28
Employees
2,56813% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
61.9 m
Valuation ($)
9.8 m
Valuation ($)
116.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
313
Twitter followers
178
Twitter followers
4.8 k
Twitter followers
195
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
0.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
36.36%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$5.2m (FY, 2019)
Revenue (est.)
(€3.6m) (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
¥1.5b (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
(€525k) (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥541m (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
(€2.6m) (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Gross profit
¥941.9m (FY, 2023)
Net income
Net income
($3.7m) (FY, 2019)
Net income
(€28.3m) (FY, 2023)
Net income
($29.8m) (FY, 2023)
Net income
($37.4m) (FY, 2023)
Net income
(¥2.5b) (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 491k
Total funding raised
$ 56m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Vivoryon Therapeutics
HQ
Halle (Saale), DE
Employees
15

Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases.

View company
Moleculin Biotech
HQ
Houston, US
Employees
19↓ 10% decrease

Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.

View company
Werewolf Therapeutics
HQ
Cambridge, US
Employees
28

Werewolf Therapeutics is an oncology biotherapeutics company that develops cancer treatments designed to focus the body’s immune response to selectively target cancer.

View company
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,568↓ 13% decrease

Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.

View company